Eli Lilly Shares Rise After Zepbound Sleep Apnea Approval
Eli Lilly sees stock surge as Zepbound receives regulatory approval for treating sleep apnea. Discover how this impacts the healthcare market.
Eli Lilly rose following regulatory approval of Zepbound for sleep apnea.